Literature DB >> 15618178

Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides.

Lisa M Harrison1, Christel van den Hoogen, Wilhelmina C E van Haaften, Vernon L Tesh.   

Abstract

Infections with Shiga toxin (Stx)-producing bacteria are associated with bloody diarrhea and postdiarrheal sequelae, including hemolytic uremic syndrome and central nervous system (CNS) abnormalities. Stx-induced intestinal, renal, and CNS vascular lesions may involve a localized production of proinflammatory cytokines in target organs, as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) up-regulate Stx receptor globotriaosylceramide (Gb(3)) expression on vascular endothelial cells. However, leukocyte recruitment to injured sites may also exacerbate vascular damage. A cytokine macroarray analysis of transcripts derived from macrophage-like THP-1 cells treated with Stx1, lipopolysaccharides (LPS), or both demonstrated a consistent up-regulation of TNF-alpha, IL-1beta, and four genes encoding the chemokines interleukin-8 (IL-8), macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and growth-related oncogene beta (GRO-beta). Real-time PCR analysis verified the macroarray results. Northern blot analyses after the addition of the transcriptional inhibitor actinomycin D revealed increased IL-8 mRNA stability in THP-1 cells treated with Stx1 or Stx1 plus LPS. Finally, enzyme-linked immunosorbent assay data for Stx1- plus LPS-treated cells demonstrated a poor correlation between IL-8, MIP-1alpha, MIP-1beta, and GRO-beta mRNA levels and protein production, indicating a posttranscriptional regulatory effect. Our data suggest that in response to Stx1 and LPS, macrophages may be a source of chemokines that promote tissue damage through leukocyte recruitment and activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15618178      PMCID: PMC538957          DOI: 10.1128/IAI.73.1.403-412.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes.

Authors:  S K Saxena; A D O'Brien; E J Ackerman
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

2.  Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1.

Authors:  A Fontaine; J Arondel; P J Sansonetti
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

3.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

Authors:  Y Endo; K Tsurugi; T Yutsudo; Y Takeda; T Ogasawara; K Igarashi
Journal:  Eur J Biochem       Date:  1988-01-15

4.  Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.

Authors:  T G Obrig; P J Del Vecchio; J E Brown; T P Moran; B M Rowland; T K Judge; S W Rothman
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

5.  Neutrophil-mediated endothelial injury in haemolytic uraemic syndrome.

Authors:  K D Forsyth; A C Simpson; M M Fitzpatrick; T M Barratt; R J Levinsky
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

6.  A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors.

Authors:  S Harrold; C Genovese; B Kobrin; S L Morrison; C Milcarek
Journal:  Anal Biochem       Date:  1991-10       Impact factor: 3.365

7.  Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

8.  Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.

Authors:  N C van de Kar; L A Monnens; M A Karmali; V W van Hinsbergh
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

9.  Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood.

Authors:  M M Fitzpatrick; V Shah; R S Trompeter; M J Dillon; T M Barratt
Journal:  Kidney Int       Date:  1992-10       Impact factor: 10.612

10.  Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.

Authors:  M Jacewicz; H Clausen; E Nudelman; A Donohue-Rolfe; G T Keusch
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  25 in total

1.  Global transcriptional response of macrophage-like THP-1 cells to Shiga toxin type 1.

Authors:  Dinorah Leyva-Illades; Rama P Cherla; Cristi L Galindo; Ashok K Chopra; Vernon L Tesh
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

2.  Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function.

Authors:  Fadila Guessous; Marek Marcinkiewicz; Renata Polanowska-Grabowska; Sudawadee Kongkhum; Daniel Heatherly; Tom Obrig; Adrian R L Gear
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Regulation of cytokine and chemokine expression by the ribotoxic stress response elicited by Shiga toxin type 1 in human macrophage-like THP-1 cells.

Authors:  Dinorah Leyva-Illades; Rama P Cherla; Moo-Seung Lee; Vernon L Tesh
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

4.  Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2.

Authors:  Erin K Lentz; Dinorah Leyva-Illades; Moo-Seung Lee; Rama P Cherla; Vernon L Tesh
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

5.  Shigella: A Highly Virulent and Elusive Pathogen.

Authors:  Mussaret Bano Zaidi; Teresa Estrada-García
Journal:  Curr Trop Med Rep       Date:  2014-06-01

Review 6.  Shiga toxins expressed by human pathogenic bacteria induce immune responses in host cells.

Authors:  Moo-Seung Lee; Myung Hee Kim; Vernon L Tesh
Journal:  J Microbiol       Date:  2013-12-19       Impact factor: 3.422

7.  The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice.

Authors:  Tania N Petruzziello-Pellegrini; Darren A Yuen; Andrea V Page; Sajedabanu Patel; Anna M Soltyk; Charles C Matouk; Dennis K Wong; Paul J Turgeon; Jason E Fish; J J David Ho; Brent M Steer; Vahid Khajoee; Jayesh Tigdi; Warren L Lee; David G Motto; Andrew Advani; Richard E Gilbert; S Ananth Karumanchi; Lisa A Robinson; Phillip I Tarr; W Conrad Liles; James L Brunton; Philip A Marsden
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

8.  Cytokine production is altered in monocytes from children with hemolytic uremic syndrome.

Authors:  Gabriela C Fernández; María V Ramos; Veronica I Landoni; Leticia V Bentancor; Romina J Fernández-Brando; Ramón Exeni; María Del Carmen Laso; Andrea Exeni; Irene Grimoldi; Martín A Isturiz; Marina S Palermo
Journal:  J Clin Immunol       Date:  2012-01-08       Impact factor: 8.317

9.  Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli.

Authors:  D J Stearns-Kurosawa; Valta Collins; Scott Freeman; Vernon L Tesh; Shinichiro Kurosawa
Journal:  Infect Immun       Date:  2010-03-22       Impact factor: 3.441

10.  Differential functional genomic effects of anti-inflammatory phytocompounds on immune signaling.

Authors:  Shao-Chih Chiu; Shan-Wen Tsao; Pei-Ing Hwang; Staniforth Vanisree; Yi-An Chen; Ning-Sun Yang
Journal:  BMC Genomics       Date:  2010-09-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.